提高基于CRISPR/Cas9的方法的内置效率的当前策略
Andrés Felipe Leal1,2, Angelica María Herreno-Pachón1,3, Eliana Benincore-Flórez1
1Nemours Children's Health, Wilmington, DE 19803, USA.
International journal of molecular sciences
|March 13, 2024
概括
克里斯普尔/Cas9基因疗法提供了精确的编辑,克服了经典基因疗法的风险. 在非同源端结合 (NHEJ) 上增强同源重组 (HDR) 是成功CRISPR基因治疗应用的关键.
科学领域:
- 生物技术是生物技术.
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- 经典的基因疗法 (GT) 使用晶状病毒 (LV) 或腺相关病毒 (AAV) 进行转基因传递,由于随机基因组合,有可能产生严重的副作用.
- 通过CRISPR/Cas9基因编辑,可以通过同源直接修复 (HDR) 实现精确的转基因插入,这种过程通常受到细胞机制限制,有利于非同源末端结合 (NHEJ).
研究的目的:
- 审查目前在基于CRISPR/Cas9的基因治疗中提高HDR效率的策略.
- 要突出CRISPR/Cas9基因组编辑在经典GT方法上的优势.
主要方法:
- 对提高HDR效率的现有方法进行全面的文献审查.
- 分析CRISPR/Cas9系统机制和细胞修复途径 (HDR与NHEJ).
主要成果:
- 经典GT方法 (LV,AAV) 在临床试验中证明了严重的不良事件.
- 对于精确的基因插入,CRISPR/Cas9需要高效的HDR,但NHEJ往往占主导地位.
- 目前正在探索各种方法来提高HDR效率,以获得更安全,更有效的基因疗法.
结论:
- 提高HDR效率对于推进基于CRISPR/Cas9的基因疗法至关重要.
- 对于精确的基因疗法,CRISPR/Cas9具有显著的前景,前提是可以有效地利用HDR.
- 对HDR增强的进一步研究对于克服当前的基因治疗挑战至关重要.
更多相关视频
07:23Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
300
05:51Construction of CRISPR Plasmids and Detection of Knockout Efficiency in Mammalian Cells through a Dual Luciferase Reporter System
Published on: December 5, 2020
6.3K
相关概念视频
CRISPR
50.9K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
50.9K
Homologous Recombination
50.5K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.5K
